Mesalamine Tablet, Delayed Release
Product Images NDC 63304-175

2 FDA label images from Sun Pharmaceutical Industries, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 63304-175). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure-mesalamine (Structure Mesalamine)

Structure-mesalamine (Structure Mesalamine)
Chemical structure diagram of mesalamine showing the molecular formula C7H7NO3 and molecular weight 153.14. The structure includes an aromatic ring with amino, hydroxyl, and carboxyl functional groups.*
FDA Label Image

Label-mesalamine (Label Mesalamine)

Label-mesalamine (Label Mesalamine)
The label is for Mesalamine Delayed-Release Tablets, USP, with a strength of 1.2 g per tablet. It is an oral tablet dosage form, available in a package containing 120 tablets. The label indicates the product is Rx only and manufactured by Sun Pharmaceutical Industries, Inc. Dosage instructions and storage conditions are noted, along with NDC 63304-175-13.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.